GIS Stock Price, Chart, Stats & News
Gilead Sciences, Inc. (GIS) is a dividend-paying stock with a current dividend yield of 2.53% as of Jun 30, 2026. It pays 2,78 € per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 0.01% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — GIS pays out about 44% of earnings.
GIS chart
About
Gilead Sciences, Inc. is a biopharmaceutical innovator dedicated to the research, development, and global commercialization of medicines that address significant unmet medical needs across the United States, Europe, and other international regions. Its extensive product lineup includes leading treatments for HIV/AIDS, such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla. For COVID-19, the company provides Veklury, an injectable therapy for intravenous administration.
Related lists
Similar securities
Based on sector and market capitalization
